General Information of This Drug (ID: DMVUZE6)

Drug Name
GZ17-6.02   DMVUZE6

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 1 [1]
Lymphoma DISN6V4S 2A80-2A86 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03775525) Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or Lymphoma (GEN602). U.S. National Institutes of Health.